PortfoliosLab logoPortfoliosLab logo
BBC vs. SBIO
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

BBC vs. SBIO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Virtus LifeSci Biotech Clinical Trials ETF (BBC) and ALPS Medical Breakthroughs ETF (SBIO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BBC achieves a 37.88% return, which is significantly higher than SBIO's 31.24% return. Over the past 10 years, BBC has underperformed SBIO with an annualized return of 11.18%, while SBIO has yielded a comparatively higher 11.79% annualized return.


BBC

1D
-3.11%
1M
23.55%
6M
34.41%
YTD
37.88%
1Y
155.13%
3Y*
31.05%
5Y*
2.03%
10Y*
11.18%

SBIO

1D
-2.49%
1M
27.41%
6M
30.85%
YTD
31.24%
1Y
108.24%
3Y*
30.52%
5Y*
7.28%
10Y*
11.79%
*Multi-year figures are annualized to reflect compound growth (CAGR)

BBC vs. SBIO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
BBC
Virtus LifeSci Biotech Clinical Trials ETF
37.88%63.77%-1.11%-1.80%-35.13%-22.31%30.32%63.81%-18.29%57.85%
SBIO
ALPS Medical Breakthroughs ETF
31.24%55.07%3.81%8.68%-28.08%-17.55%21.17%50.30%-11.81%45.67%

Correlation

The correlation between BBC and SBIO is 0.93, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.93

Correlation (3Y)
Calculated over the trailing 3-year period

0.94

Correlation (5Y)
Calculated over the trailing 5-year period

0.95

Correlation (10Y)
Calculated over the trailing 10-year period

0.94

Correlation (All Time)
Calculated using the full available price history since Dec 31, 2014

0.94

The correlation between BBC and SBIO has been stable across timeframes, ranging from 0.93 to 0.95 - a consistent structural relationship.

BBC vs. SBIO - Sectors Allocation Comparison


Sectors
BBC
SBIO

Healthcare

99.0%
100.0%

Financial Services

0.8%
-0.0%

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

BBC
99.0%
SBIO
100.0%

Financial Services

BBC
0.8%
SBIO
-0.0%

Basic Materials

BBC

-

SBIO

-

Communication Services

BBC

-

SBIO

-

Consumer Cyclical

BBC

-

SBIO

-

Consumer Defensive

BBC

-

SBIO

-

Energy

BBC

-

SBIO

-

Industrials

BBC

-

SBIO

-

Real Estate

BBC

-

SBIO

-

Technology

BBC

-

SBIO

-

Utilities

BBC

-

SBIO

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BBC vs. SBIO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BBC
BBC Risk / Return Rank: 9696
Overall Rank
BBC Sharpe Ratio Rank: 9898
Sharpe Ratio Rank
BBC Sortino Ratio Rank: 9696
Sortino Ratio Rank
BBC Omega Ratio Rank: 9494
Omega Ratio Rank
BBC Calmar Ratio Rank: 9898
Calmar Ratio Rank
BBC Martin Ratio Rank: 9696
Martin Ratio Rank

SBIO
SBIO Risk / Return Rank: 9595
Overall Rank
SBIO Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
SBIO Sortino Ratio Rank: 9595
Sortino Ratio Rank
SBIO Omega Ratio Rank: 9393
Omega Ratio Rank
SBIO Calmar Ratio Rank: 9797
Calmar Ratio Rank
SBIO Martin Ratio Rank: 9595
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BBC vs. SBIO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Clinical Trials ETF (BBC) and ALPS Medical Breakthroughs ETF (SBIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


BBCSBIODifference
Sharpe ratioReturn per unit of total volatility

+0.75

Sortino ratioReturn per unit of downside risk

+0.26

Omega ratioGain probability vs. loss probability

1.54

1.51

+0.03

Calmar ratioReturn relative to maximum drawdown

10.07

8.38

+1.69

Martin ratioReturn relative to average drawdown

29.52

23.39

+6.13

BBC vs. SBIO - Sharpe Ratio Comparison

The current BBC Sharpe Ratio is 4.23, which is comparable to the SBIO Sharpe Ratio of 3.48. The chart below compares the historical Sharpe Ratios of BBC and SBIO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

BBC vs. SBIO - Drawdown Comparison

The maximum BBC drawdown since its inception was -76.85%, which is greater than SBIO's maximum drawdown of -63.06%. Use the drawdown chart below to compare losses from any high point for BBC and SBIO.


Loading charts...

Drawdown Indicators


BBCSBIODifference

Max Drawdown

Largest peak-to-trough decline

-76.85%

-63.06%

-13.79%

Max Drawdown (1Y)

Largest decline over 1 year

-15.10%

-12.66%

-2.44%

Max Drawdown (3Y)

Largest decline over 3 years

-54.45%

-42.44%

-12.01%

Max Drawdown (5Y)

Largest decline over 5 years

-70.92%

-52.49%

-18.43%

Max Drawdown (10Y)

Largest decline over 10 years

-76.85%

-63.06%

-13.79%

Current Drawdown

Current decline from peak

-11.50%

-2.49%

-9.01%

Average Drawdown

Average peak-to-trough decline

-36.98%

-28.25%

-8.73%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.14%

4.53%

+0.61%

Volatility

BBC vs. SBIO - Volatility Comparison

Virtus LifeSci Biotech Clinical Trials ETF (BBC) and ALPS Medical Breakthroughs ETF (SBIO) have volatilities of 9.71% and 9.67%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BBCSBIODifference

Volatility (1M)

Calculated over the trailing 1-month period

9.71%

9.67%

+0.04%

Volatility (6M)

Calculated over the trailing 6-month period

26.07%

23.83%

+2.24%

Volatility (1Y)

Calculated over the trailing 1-year period

35.96%

30.48%

+5.48%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

39.56%

33.86%

+5.70%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

37.69%

33.15%

+4.54%

BBC vs. SBIO - Expense Ratio Comparison

BBC has a 0.79% expense ratio, which is higher than SBIO's 0.50% expense ratio.


Dividends

BBC vs. SBIO - Dividend Comparison

BBC's dividend yield for the trailing twelve months is around 1.23%, while SBIO has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
BBC
Virtus LifeSci Biotech Clinical Trials ETF
1.23%1.70%1.00%0.34%0.00%0.00%0.00%0.00%0.00%2.09%0.00%0.51%
SBIO
ALPS Medical Breakthroughs ETF
0.00%0.00%3.55%0.22%0.00%0.00%0.00%0.04%2.79%1.77%0.00%0.00%

Frequently Asked Questions


With a correlation of 0.93, BBC and SBIO move almost identically. Holding both adds very little diversification - you're essentially doubling your position in the same market segment. Choosing one is usually more capital-efficient.

BBC has higher volatility (9.71%) compared to SBIO (9.67%). In terms of maximum drawdown, BBC dropped -76.85% vs SBIO's -63.06%.

On 10-year performance, SBIO leads with 11.79% vs 11.18% for BBC. On fees, SBIO is cheaper at 0.50% per year. Their volatility is very similar. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, SBIO has performed better with a 11.79% return vs 11.18%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

SBIO is cheaper with a 0.50% expense ratio, compared with 0.79% for BBC.

BBC has the higher dividend yield at 1.23%, compared with 0.00% for SBIO.

BBC tracks LifeSci Biotechnology Clinical Trials Index, while SBIO tracks S-Network Medical Breakthroughs Index. They also come from different issuers: Virtus Investment Partners and SS&C. Their fees differ too: 0.79% for BBC and 0.50% for SBIO.

BBC currently has the higher Sharpe Ratio (4.23 vs 3.48), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BBC and SBIO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer